nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzphetamine—CYP2B6—Simvastatin—atherosclerosis	0.26	0.389	CbGbCtD
Benzphetamine—CYP3A4—Rosuvastatin—atherosclerosis	0.0859	0.129	CbGbCtD
Benzphetamine—CYP3A4—Ezetimibe—atherosclerosis	0.0859	0.129	CbGbCtD
Benzphetamine—CYP3A4—Simvastatin—atherosclerosis	0.0799	0.12	CbGbCtD
Benzphetamine—CYP3A4—Lovastatin—atherosclerosis	0.0781	0.117	CbGbCtD
Benzphetamine—CYP3A4—Pravastatin—atherosclerosis	0.0781	0.117	CbGbCtD
Benzphetamine—Sweating—Niacin—atherosclerosis	0.00336	0.0244	CcSEcCtD
Benzphetamine—Tremor—Lovastatin—atherosclerosis	0.00299	0.0217	CcSEcCtD
Benzphetamine—Tremor—Simvastatin—atherosclerosis	0.00279	0.0203	CcSEcCtD
Benzphetamine—Insomnia—Rosuvastatin—atherosclerosis	0.00278	0.0202	CcSEcCtD
Benzphetamine—Palpitations—Ezetimibe—atherosclerosis	0.00276	0.0201	CcSEcCtD
Benzphetamine—Dyspepsia—Rosuvastatin—atherosclerosis	0.0027	0.0196	CcSEcCtD
Benzphetamine—Antazoline—HRH1—atherosclerosis	0.00267	0.109	CrCbGaD
Benzphetamine—Tremor—Pravastatin—atherosclerosis	0.00252	0.0183	CcSEcCtD
Benzphetamine—Anorexia—Lovastatin—atherosclerosis	0.00248	0.018	CcSEcCtD
Benzphetamine—Urticaria—Rosuvastatin—atherosclerosis	0.00244	0.0177	CcSEcCtD
Benzphetamine—Palpitations—Niacin—atherosclerosis	0.00242	0.0176	CcSEcCtD
Benzphetamine—Insomnia—Lovastatin—atherosclerosis	0.00235	0.0171	CcSEcCtD
Benzphetamine—Anorexia—Simvastatin—atherosclerosis	0.00232	0.0168	CcSEcCtD
Benzphetamine—Insomnia—Ezetimibe—atherosclerosis	0.00231	0.0168	CcSEcCtD
Benzphetamine—Dyspepsia—Lovastatin—atherosclerosis	0.00229	0.0166	CcSEcCtD
Benzphetamine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00226	0.0164	CcSEcCtD
Benzphetamine—Decreased appetite—Lovastatin—atherosclerosis	0.00226	0.0164	CcSEcCtD
Benzphetamine—Dyspepsia—Ezetimibe—atherosclerosis	0.00225	0.0163	CcSEcCtD
Benzphetamine—Pheniramine—HRH1—atherosclerosis	0.00222	0.0904	CrCbGaD
Benzphetamine—Decreased appetite—Ezetimibe—atherosclerosis	0.00222	0.0161	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.0022	0.016	CcSEcCtD
Benzphetamine—Insomnia—Simvastatin—atherosclerosis	0.0022	0.016	CcSEcCtD
Benzphetamine—Tachycardia—Niacin—atherosclerosis	0.00218	0.0158	CcSEcCtD
Benzphetamine—Hyperhidrosis—Niacin—atherosclerosis	0.00216	0.0157	CcSEcCtD
Benzphetamine—Dyspepsia—Simvastatin—atherosclerosis	0.00214	0.0155	CcSEcCtD
Benzphetamine—Anorexia—Niacin—atherosclerosis	0.00213	0.0155	CcSEcCtD
Benzphetamine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00213	0.0154	CcSEcCtD
Benzphetamine—Decreased appetite—Simvastatin—atherosclerosis	0.00211	0.0154	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.0021	0.0152	CcSEcCtD
Benzphetamine—Diarrhoea—Rosuvastatin—atherosclerosis	0.0021	0.0152	CcSEcCtD
Benzphetamine—Anorexia—Pravastatin—atherosclerosis	0.0021	0.0152	CcSEcCtD
Benzphetamine—Urticaria—Lovastatin—atherosclerosis	0.00207	0.015	CcSEcCtD
Benzphetamine—Dizziness—Rosuvastatin—atherosclerosis	0.00203	0.0147	CcSEcCtD
Benzphetamine—Urticaria—Ezetimibe—atherosclerosis	0.00203	0.0147	CcSEcCtD
Benzphetamine—Clofedanol—HRH1—atherosclerosis	0.00202	0.0823	CrCbGaD
Benzphetamine—Insomnia—Niacin—atherosclerosis	0.00202	0.0147	CcSEcCtD
Benzphetamine—Insomnia—Pravastatin—atherosclerosis	0.00199	0.0144	CcSEcCtD
Benzphetamine—Dyspepsia—Niacin—atherosclerosis	0.00197	0.0143	CcSEcCtD
Benzphetamine—Decreased appetite—Niacin—atherosclerosis	0.00194	0.0141	CcSEcCtD
Benzphetamine—Dyspepsia—Pravastatin—atherosclerosis	0.00194	0.0141	CcSEcCtD
Benzphetamine—Urticaria—Simvastatin—atherosclerosis	0.00193	0.014	CcSEcCtD
Benzphetamine—Gastrointestinal disorder—Niacin—atherosclerosis	0.00193	0.014	CcSEcCtD
Benzphetamine—Headache—Rosuvastatin—atherosclerosis	0.00192	0.014	CcSEcCtD
Benzphetamine—Hypersensitivity—Lovastatin—atherosclerosis	0.00192	0.0139	CcSEcCtD
Benzphetamine—Decreased appetite—Pravastatin—atherosclerosis	0.00191	0.0139	CcSEcCtD
Benzphetamine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00188	0.0136	CcSEcCtD
Benzphetamine—Doxylamine—HRH1—atherosclerosis	0.00185	0.0753	CrCbGaD
Benzphetamine—Nausea—Rosuvastatin—atherosclerosis	0.00182	0.0132	CcSEcCtD
Benzphetamine—Hypersensitivity—Simvastatin—atherosclerosis	0.00179	0.013	CcSEcCtD
Benzphetamine—Diarrhoea—Lovastatin—atherosclerosis	0.00178	0.0129	CcSEcCtD
Benzphetamine—Urticaria—Niacin—atherosclerosis	0.00177	0.0129	CcSEcCtD
Benzphetamine—Tripelennamine—HRH1—atherosclerosis	0.00176	0.0716	CrCbGaD
Benzphetamine—Diphenylpyraline—HRH1—atherosclerosis	0.00176	0.0716	CrCbGaD
Benzphetamine—Urticaria—Pravastatin—atherosclerosis	0.00175	0.0127	CcSEcCtD
Benzphetamine—Diarrhoea—Ezetimibe—atherosclerosis	0.00175	0.0127	CcSEcCtD
Benzphetamine—Dizziness—Lovastatin—atherosclerosis	0.00172	0.0125	CcSEcCtD
Benzphetamine—Dizziness—Ezetimibe—atherosclerosis	0.00169	0.0122	CcSEcCtD
Benzphetamine—Diarrhoea—Simvastatin—atherosclerosis	0.00166	0.0121	CcSEcCtD
Benzphetamine—Hypersensitivity—Niacin—atherosclerosis	0.00165	0.0119	CcSEcCtD
Benzphetamine—Headache—Lovastatin—atherosclerosis	0.00163	0.0118	CcSEcCtD
Benzphetamine—Hypersensitivity—Pravastatin—atherosclerosis	0.00162	0.0118	CcSEcCtD
Benzphetamine—Dizziness—Simvastatin—atherosclerosis	0.00161	0.0117	CcSEcCtD
Benzphetamine—Headache—Ezetimibe—atherosclerosis	0.0016	0.0116	CcSEcCtD
Benzphetamine—Alimemazine—HRH1—atherosclerosis	0.00159	0.0646	CrCbGaD
Benzphetamine—Nausea—Lovastatin—atherosclerosis	0.00154	0.0112	CcSEcCtD
Benzphetamine—Diarrhoea—Niacin—atherosclerosis	0.00153	0.0111	CcSEcCtD
Benzphetamine—Headache—Simvastatin—atherosclerosis	0.00152	0.0111	CcSEcCtD
Benzphetamine—Nausea—Ezetimibe—atherosclerosis	0.00152	0.011	CcSEcCtD
Benzphetamine—Diarrhoea—Pravastatin—atherosclerosis	0.0015	0.0109	CcSEcCtD
Benzphetamine—Dizziness—Niacin—atherosclerosis	0.00148	0.0107	CcSEcCtD
Benzphetamine—Dizziness—Pravastatin—atherosclerosis	0.00145	0.0106	CcSEcCtD
Benzphetamine—Bromodiphenhydramine—HRH1—atherosclerosis	0.00145	0.0589	CrCbGaD
Benzphetamine—Nausea—Simvastatin—atherosclerosis	0.00144	0.0105	CcSEcCtD
Benzphetamine—Cyclizine—HRH1—atherosclerosis	0.00142	0.0576	CrCbGaD
Benzphetamine—Headache—Niacin—atherosclerosis	0.0014	0.0102	CcSEcCtD
Benzphetamine—Headache—Pravastatin—atherosclerosis	0.00138	0.01	CcSEcCtD
Benzphetamine—Benzatropine—HRH1—atherosclerosis	0.00135	0.0549	CrCbGaD
Benzphetamine—Nausea—Niacin—atherosclerosis	0.00133	0.00963	CcSEcCtD
Benzphetamine—Nausea—Pravastatin—atherosclerosis	0.00131	0.00948	CcSEcCtD
Benzphetamine—Toremifene—ESR1—atherosclerosis	0.000878	0.0357	CrCbGaD
Benzphetamine—Trimipramine—HRH1—atherosclerosis	0.000707	0.0288	CrCbGaD
Benzphetamine—Diphenhydramine—HRH1—atherosclerosis	0.000694	0.0282	CrCbGaD
Benzphetamine—Promethazine—HRH1—atherosclerosis	0.000681	0.0277	CrCbGaD
Benzphetamine—Orphenadrine—HRH1—atherosclerosis	0.000657	0.0267	CrCbGaD
Benzphetamine—Promazine—HRH1—atherosclerosis	0.000599	0.0244	CrCbGaD
Benzphetamine—Tamoxifen—ESR2—atherosclerosis	0.000569	0.0232	CrCbGaD
Benzphetamine—Oxaprozin—PTGS2—atherosclerosis	0.0005	0.0204	CrCbGaD
Benzphetamine—Tamoxifen—ESR1—atherosclerosis	0.000351	0.0143	CrCbGaD
Benzphetamine—Phenylbutazone—PTGS2—atherosclerosis	0.000331	0.0135	CrCbGaD
Benzphetamine—Phenprocoumon—ALB—atherosclerosis	0.000318	0.0129	CrCbGaD
Benzphetamine—Phenytoin—ALB—atherosclerosis	0.000205	0.00833	CrCbGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CCL5—atherosclerosis	6.33e-05	0.000373	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—IGF1—atherosclerosis	6.31e-05	0.000371	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PLTP—atherosclerosis	6.24e-05	0.000368	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CNR2—atherosclerosis	6.11e-05	0.00036	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CX3CR1—atherosclerosis	6.1e-05	0.000359	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CASR—atherosclerosis	6.1e-05	0.000359	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR ligand binding—CXCL8—atherosclerosis	6.1e-05	0.000359	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—MMP3—atherosclerosis	6.09e-05	0.000359	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—NAMPT—atherosclerosis	6.09e-05	0.000358	CbGpPWpGaD
Benzphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	6.08e-05	0.000358	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—LIPC—atherosclerosis	6.05e-05	0.000356	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PRKCG—atherosclerosis	6.02e-05	0.000355	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—APOC3—atherosclerosis	6.01e-05	0.000354	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—SERPINE1—atherosclerosis	5.99e-05	0.000353	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CX3CL1—atherosclerosis	5.99e-05	0.000352	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—ALB—atherosclerosis	5.98e-05	0.000352	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—LDLR—atherosclerosis	5.97e-05	0.000352	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—EDN1—atherosclerosis	5.93e-05	0.000349	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CCL5—atherosclerosis	5.88e-05	0.000346	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CETP—atherosclerosis	5.84e-05	0.000344	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—EDN1—atherosclerosis	5.8e-05	0.000341	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CCL5—atherosclerosis	5.75e-05	0.000339	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—NOS3—atherosclerosis	5.72e-05	0.000337	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—NAMPT—atherosclerosis	5.71e-05	0.000336	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CNR2—atherosclerosis	5.67e-05	0.000334	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR ligand binding—CXCL8—atherosclerosis	5.67e-05	0.000334	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—LIPC—atherosclerosis	5.67e-05	0.000334	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—MMP3—atherosclerosis	5.66e-05	0.000333	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—APOC3—atherosclerosis	5.64e-05	0.000332	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—LDLR—atherosclerosis	5.6e-05	0.00033	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PRKCG—atherosclerosis	5.59e-05	0.000329	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—SCARB1—atherosclerosis	5.59e-05	0.000329	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CETP—atherosclerosis	5.47e-05	0.000322	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PRKCG—atherosclerosis	5.47e-05	0.000322	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—VWF—atherosclerosis	5.44e-05	0.000321	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ABCG8—atherosclerosis	5.41e-05	0.000319	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—LTA4H—atherosclerosis	5.41e-05	0.000319	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APOC3—atherosclerosis	5.41e-05	0.000319	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—EDN1—atherosclerosis	5.38e-05	0.000317	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—LDLR—atherosclerosis	5.38e-05	0.000317	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CCL5—atherosclerosis	5.34e-05	0.000315	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—AGT—atherosclerosis	5.3e-05	0.000312	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—HMGCR—atherosclerosis	5.28e-05	0.000311	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCL3—atherosclerosis	5.25e-05	0.000309	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—SCARB1—atherosclerosis	5.24e-05	0.000309	CbGpPWpGaD
Benzphetamine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	5.1e-05	0.0003	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PRKCG—atherosclerosis	5.08e-05	0.000299	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—VWF—atherosclerosis	5.06e-05	0.000298	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NCF1—atherosclerosis	5.03e-05	0.000296	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APOC3—atherosclerosis	5.03e-05	0.000296	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—LDLR—atherosclerosis	5e-05	0.000294	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—HMGCR—atherosclerosis	4.95e-05	0.000291	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—AGT—atherosclerosis	4.92e-05	0.00029	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—F2—atherosclerosis	4.89e-05	0.000288	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCL3—atherosclerosis	4.88e-05	0.000287	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—AGT—atherosclerosis	4.81e-05	0.000283	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EDNRA—atherosclerosis	4.75e-05	0.00028	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCR2—atherosclerosis	4.75e-05	0.00028	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CYBA—atherosclerosis	4.73e-05	0.000278	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ABCA1—atherosclerosis	4.7e-05	0.000277	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—PIK3CG—atherosclerosis	4.68e-05	0.000276	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NCF1—atherosclerosis	4.67e-05	0.000275	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PARP1—atherosclerosis	4.63e-05	0.000273	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—GHRL—atherosclerosis	4.63e-05	0.000273	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PLAT—atherosclerosis	4.63e-05	0.000273	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—F2—atherosclerosis	4.55e-05	0.000268	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—AGT—atherosclerosis	4.47e-05	0.000263	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—F2—atherosclerosis	4.44e-05	0.000262	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EDNRA—atherosclerosis	4.41e-05	0.00026	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCR2—atherosclerosis	4.41e-05	0.00026	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ABCA1—atherosclerosis	4.41e-05	0.00026	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CYBA—atherosclerosis	4.39e-05	0.000259	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—PIK3CG—atherosclerosis	4.35e-05	0.000256	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PLAT—atherosclerosis	4.3e-05	0.000253	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—GHRL—atherosclerosis	4.3e-05	0.000253	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PARP1—atherosclerosis	4.3e-05	0.000253	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ABCG1—atherosclerosis	4.28e-05	0.000252	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—PIK3CG—atherosclerosis	4.25e-05	0.00025	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—F2—atherosclerosis	4.13e-05	0.000243	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—VEGFA—atherosclerosis	4.12e-05	0.000243	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—KNG1—atherosclerosis	4.06e-05	0.000239	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AGTR1—atherosclerosis	4.04e-05	0.000238	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—HMOX1—atherosclerosis	4.04e-05	0.000238	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—LCAT—atherosclerosis	4.02e-05	0.000237	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—FABP4—atherosclerosis	4.02e-05	0.000237	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CCL2—atherosclerosis	3.96e-05	0.000233	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—PIK3CG—atherosclerosis	3.95e-05	0.000233	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APOA4—atherosclerosis	3.95e-05	0.000233	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PLG—atherosclerosis	3.94e-05	0.000232	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—MAPK3—atherosclerosis	3.9e-05	0.000229	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	3.88e-05	0.000229	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—APOB—atherosclerosis	3.87e-05	0.000228	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—HMOX1—atherosclerosis	3.78e-05	0.000223	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—TGFB1—atherosclerosis	3.78e-05	0.000223	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—KNG1—atherosclerosis	3.77e-05	0.000222	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GSTM1—atherosclerosis	3.76e-05	0.000221	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AGTR1—atherosclerosis	3.75e-05	0.000221	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SOCS3—atherosclerosis	3.73e-05	0.000219	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—LPL—atherosclerosis	3.69e-05	0.000217	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CCL2—atherosclerosis	3.68e-05	0.000217	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PLG—atherosclerosis	3.66e-05	0.000215	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—APOB—atherosclerosis	3.62e-05	0.000213	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—GPX1—atherosclerosis	3.6e-05	0.000212	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	3.6e-05	0.000212	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	3.59e-05	0.000211	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	3.58e-05	0.000211	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GSTM1—atherosclerosis	3.53e-05	0.000208	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CD36—atherosclerosis	3.51e-05	0.000207	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APOB—atherosclerosis	3.48e-05	0.000205	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SOCS3—atherosclerosis	3.46e-05	0.000204	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—LPL—atherosclerosis	3.46e-05	0.000204	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	3.45e-05	0.000203	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	3.42e-05	0.000202	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	3.4e-05	0.0002	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ALOX15—atherosclerosis	3.4e-05	0.0002	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	3.4e-05	0.0002	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APOA2—atherosclerosis	3.4e-05	0.0002	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	3.4e-05	0.0002	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—GPX1—atherosclerosis	3.38e-05	0.000199	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ABCG5—atherosclerosis	3.36e-05	0.000198	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MMP3—atherosclerosis	3.34e-05	0.000197	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IGF2—atherosclerosis	3.33e-05	0.000196	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—MTHFR—atherosclerosis	3.32e-05	0.000196	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—LPL—atherosclerosis	3.32e-05	0.000196	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CD36—atherosclerosis	3.29e-05	0.000194	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PPARA—atherosclerosis	3.26e-05	0.000192	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—LPA—atherosclerosis	3.24e-05	0.000191	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APOB—atherosclerosis	3.23e-05	0.00019	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	3.23e-05	0.00019	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—CXCL8—atherosclerosis	3.2e-05	0.000189	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—EDN1—atherosclerosis	3.18e-05	0.000187	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—AGT—atherosclerosis	3.16e-05	0.000186	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCL5—atherosclerosis	3.16e-05	0.000186	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	3.15e-05	0.000185	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—BGN—atherosclerosis	3.14e-05	0.000185	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	3.13e-05	0.000184	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—MTHFR—atherosclerosis	3.12e-05	0.000183	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APOA5—atherosclerosis	3.11e-05	0.000183	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—APOE—atherosclerosis	3.09e-05	0.000182	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—LPL—atherosclerosis	3.09e-05	0.000182	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—CAV1—atherosclerosis	3.07e-05	0.000181	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—APOA1—atherosclerosis	3.06e-05	0.00018	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PPARA—atherosclerosis	3.06e-05	0.00018	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PRKCG—atherosclerosis	3e-05	0.000177	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.99e-05	0.000176	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—AGT—atherosclerosis	2.96e-05	0.000174	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SPP1—atherosclerosis	2.92e-05	0.000172	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	2.91e-05	0.000171	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—CXCL8—atherosclerosis	2.91e-05	0.000171	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—APOE—atherosclerosis	2.9e-05	0.000171	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.89e-05	0.00017	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—CAV1—atherosclerosis	2.87e-05	0.000169	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—APOA1—atherosclerosis	2.87e-05	0.000169	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AGT—atherosclerosis	2.84e-05	0.000167	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PIK3CG—atherosclerosis	2.79e-05	0.000164	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APOE—atherosclerosis	2.78e-05	0.000164	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—LEP—atherosclerosis	2.78e-05	0.000164	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	2.76e-05	0.000162	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	2.75e-05	0.000162	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PDGFB—atherosclerosis	2.7e-05	0.000159	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PPARG—atherosclerosis	2.69e-05	0.000159	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	2.66e-05	0.000157	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—INS—atherosclerosis	2.64e-05	0.000156	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AGT—atherosclerosis	2.64e-05	0.000155	CbGpPWpGaD
Benzphetamine—ADRA2A—Hemostasis—AKT1—atherosclerosis	2.63e-05	0.000155	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—F2—atherosclerosis	2.63e-05	0.000155	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PIK3CG—atherosclerosis	2.62e-05	0.000154	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.59e-05	0.000153	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APOE—atherosclerosis	2.59e-05	0.000152	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—LEP—atherosclerosis	2.59e-05	0.000152	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—LIPC—atherosclerosis	2.58e-05	0.000152	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	2.56e-05	0.000151	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APOC3—atherosclerosis	2.56e-05	0.000151	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	2.56e-05	0.000151	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—LDLR—atherosclerosis	2.55e-05	0.00015	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PPARG—atherosclerosis	2.53e-05	0.000149	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	2.51e-05	0.000148	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CETP—atherosclerosis	2.49e-05	0.000146	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—INS—atherosclerosis	2.48e-05	0.000146	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	2.47e-05	0.000145	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—F2—atherosclerosis	2.44e-05	0.000144	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—ALB—atherosclerosis	2.42e-05	0.000143	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	2.41e-05	0.000142	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.38e-05	0.00014	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—INS—atherosclerosis	2.38e-05	0.00014	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	2.34e-05	0.000138	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	2.33e-05	0.000137	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—NOS3—atherosclerosis	2.32e-05	0.000136	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	2.3e-05	0.000135	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—ALB—atherosclerosis	2.27e-05	0.000134	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.25e-05	0.000132	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	2.24e-05	0.000132	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—INS—atherosclerosis	2.21e-05	0.00013	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	2.18e-05	0.000129	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	2.17e-05	0.000128	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—NOS3—atherosclerosis	2.17e-05	0.000128	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	2.14e-05	0.000126	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—PTGS2—atherosclerosis	2.12e-05	0.000125	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	2.09e-05	0.000123	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	2.03e-05	0.00012	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ABCA1—atherosclerosis	2e-05	0.000118	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—PTGS2—atherosclerosis	1.99e-05	0.000117	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	1.94e-05	0.000114	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	1.85e-05	0.000109	CbGpPWpGaD
Benzphetamine—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	1.79e-05	0.000105	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	1.76e-05	0.000104	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.72e-05	0.000101	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	1.72e-05	0.000101	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	1.67e-05	9.86e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	1.66e-05	9.78e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	1.66e-05	9.75e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APOB—atherosclerosis	1.65e-05	9.7e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	1.63e-05	9.63e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	1.63e-05	9.58e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	1.62e-05	9.56e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.6e-05	9.43e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—LPL—atherosclerosis	1.57e-05	9.26e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	1.55e-05	9.16e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	1.54e-05	9.06e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—GPX1—atherosclerosis	1.53e-05	9.03e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	1.51e-05	8.91e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	1.51e-05	8.88e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	1.5e-05	8.85e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CD36—atherosclerosis	1.49e-05	8.8e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	1.49e-05	8.76e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	1.42e-05	8.37e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.42e-05	8.34e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	1.4e-05	8.22e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PPARA—atherosclerosis	1.39e-05	8.18e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	1.38e-05	8.14e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	1.38e-05	8.12e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AGT—atherosclerosis	1.35e-05	7.92e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	1.32e-05	7.78e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APOE—atherosclerosis	1.32e-05	7.76e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—CAV1—atherosclerosis	1.31e-05	7.69e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—APOA1—atherosclerosis	1.3e-05	7.67e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	1.28e-05	7.55e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.19e-05	7.01e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PPARG—atherosclerosis	1.15e-05	6.76e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—INS—atherosclerosis	1.13e-05	6.63e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Metabolism—AKT1—atherosclerosis	1.07e-05	6.27e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—IL6—atherosclerosis	1.04e-05	6.12e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—ALB—atherosclerosis	1.03e-05	6.08e-05	CbGpPWpGaD
Benzphetamine—CYP2B6—Metabolism—AKT1—atherosclerosis	9.99e-06	5.88e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—NOS3—atherosclerosis	9.87e-06	5.82e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—IL6—atherosclerosis	9.66e-06	5.69e-05	CbGpPWpGaD
Benzphetamine—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	9.59e-06	5.65e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—PTGS2—atherosclerosis	9.03e-06	5.32e-05	CbGpPWpGaD
Benzphetamine—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	8.91e-06	5.25e-05	CbGpPWpGaD
Benzphetamine—CYP3A4—Metabolism—AKT1—atherosclerosis	4.54e-06	2.67e-05	CbGpPWpGaD
